INS and inherited lipid metabolism disorder: These targets would be attainable with intensive insulin treatment (69.3% vs. 67.5%) and a high-rate usage of statin (76.8% vs. 73.3%)—or with dyslipidaemia therapy (78.6% vs. 78.6%)—during follow-up treatment in Beijing and Taiyuan.